By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Kiadis Pharma 

Zernikepark 6-8

Groningen    9747 AN  The Netherlands
Phone: 31-0-50-547-42-70 Fax: 31-0-50-547-42-71


SEARCH JOBS



Segment
Oncology





Company News
Kiadis Pharma Announces Annual Results For The Year Ended 31 December 2015 4/15/2016 8:41:10 AM
Kiadis Pharma Proposes Robert Soiffer And Berndt Modig As Its New Supervisory Board Members 4/7/2016 9:31:58 AM
Kiadis Pharma Presents Positive Data On The Primary Endpoint Of Its Single Dose Phase II Trial With ATIR101 4/4/2016 10:14:38 AM
Kiadis Pharma To Host A Webcast Of The Full Dataset On The Primary Endpoint Of Its Single-Dose Phase II Trial With ATIR101 3/29/2016 9:08:32 AM
Kiadis Pharma Satellite Symposium At 42nd Annual Meeting Of The European Society For Blood And Marrow Transplantation 3/14/2016 10:22:50 AM
Top-Line Data From All Patients On The Primary Endpoint Of Kiadis Pharma’s Phase II Trial With ATIR101 Selected For Oral Presentation At 42nd Annual Meeting Of The European Society For Blood And Marrow Transplantation 3/1/2016 10:17:58 AM
Kiadis Pharma And The Leukemia & Lymphoma Society Enter Partnership For The Development Of ATIR101 In ALL And AML Patients 2/1/2016 9:24:56 AM
Kiadis Pharma Announces A Global Collaboration With The Thalassaemia International Federation 12/21/2015 12:24:48 PM
Kiadis Pharma Utilizes BioLife Solutions, Inc. (BLFS.OB) HypoThermosol To Improve Viability And Shelf Life Of Donor Leukocytes In Clinical Trial Of ATIR101 T Cell Therapy For Blood Cancers 10/19/2015 9:29:33 AM
European Medicines Agency Grants Kiadis Pharma's Lead Product ATIR ATMP Certificate For Quality And Non-Clinical Data 5/13/2015 6:26:46 AM
12345
//-->